Raynaud syndrome

Raynaud syndrome, also known as Raynaud's phenomenon, is a medical condition in which the spasm of small arteries causes episodes of reduced blood flow to end arterioles. Typically, the fingers, and less commonly, the toes, are involved. Rarely, the nose, ears, nipples, or lips are affected. The episodes classically result in the affected part turning white and then blue. Often, numbness or pain occurs. As blood flow returns, the area turns red and burns. The episodes typically last minutes but can last several hours. The condition is named after the physician Auguste Gabriel Maurice Raynaud, who first described it in his doctoral thesis in 1862.

Raynaud syndrome
Other namesRaynaud's, Raynaud's disease, Raynaud's phenomenon, Raynaud's syndrome
The hand of a person with Raynaud syndrome during an attack.
Pronunciation
  • /rˈn/ ray-NOH
SpecialtyRheumatology
SymptomsAn affected part turning white, then blue, then red, burning
Complicationsskin sores, gangrene
Usual onset15–30 year old, typically females
DurationUp to several hours per episode
Risk factorsCold, emotional stress
Diagnostic methodBased on the symptoms
Differential diagnosisCausalgia, erythromelalgia
TreatmentAvoiding cold, calcium channel blockers, iloprost
Frequency4% of people
Named afterMaurice Raynaud

Episodes are typically triggered by cold or emotional stress. Primary Raynaud's is idiopathic (spontaneous and of unknown cause) and not correlated with another disease. Secondary Raynaud's occurs as a result of some other condition and has an older age at onset; episodes are intensely painful and can be asymmetric and associated with skin lesions. Secondary Raynaud's can occur due to a connective-tissue disorder such as scleroderma or lupus, injuries to the hands, prolonged vibration, smoking, thyroid problems, and certain medications, such as birth control pills and stimulants. Diagnosis is typically based on the symptoms.

The primary treatment is avoiding the cold. Other measures include the discontinuation of nicotine or stimulant use. Medications for treatment of cases that do not improve include calcium channel blockers and iloprost. Little evidence supports alternative medicine. Severe disease may in rare cases lead to complications, specifically skin sores or gangrene.

About 4% of people have the condition. Onset of the primary form is typically between ages 15 and 30 and occurs more frequently in females. The secondary form usually affects older people. Both forms are more common in cold climates.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.